Isosorbide mononitrate dosage forms and strengths

Revision as of 03:03, 31 January 2014 by Pratik Bahekar (talk | contribs)
Jump to navigation Jump to search
Isosorbide mononitrate
ISOSORBIDE MONONITRATE tablet® FDA Package Insert
Indications and Usage
Dosage and Administration
Dosage Forms and Strengths
Contraindications
Warnings and Precautions
Adverse Reactions
Drug Interactions
Overdosage
Description
Clinical Pharmacology
Clinical Studies
How Supplied/Storage and Handling
Patient Counseling Information
Labels and Packages
Clinical Trials
ClinicalTrials.gov

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Pratik Bahekar, MBBS [2]


Isosorbide mononitrate extended-release 30 mg tablets are oval, reddish pink, film-coated tablets, debossed “N” bisect “30” on one side and bisect on the other side, packaged as follows:

  • NDC 68382-650-01 bottle of 100 tablets
  • NDC 68382-650-05 bottle of 500 tablets


Isosorbide mononitrate extended-release 60 mg tablets are oval, yellow, film-coated tablets, debossed “N” bisect “60” on one side and bisect on the other side, packaged as follows:

  • NDC 68382-651-01 bottle of 100 tablets
  • NDC 68382-651-05 bottle of 500 tablets[1]

References

  1. "ISOSORBIDE MONONITRATE TABLET [ZYDUS PHARMACEUTICALS (USA) INC.]". Retrieved 30 January 2014.